• Home
  • Search Results

Search Results

Open
Young Adult (18-34)
352 studies match your search
Open

Autologous Anti-HER2 Chimeric Antigen Receptor Monocytes (CT-0525) in Participants with HER2 Over Expressing Solid Tumors

Do you have an advanced form of cancer that has not responded well to previous therapies? Are there no other curative therapies? If so, you may be able to participate in this cell therapy research study to learn more about using your own modified immune cells as possible treatment.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Phase 1 Trials (all cancers))
Open

Latinos with Newly Diagnosed Type II Diabetes

Are you Hispanic and have been recently diagnosed with Type 2 Diabetes? You may be able to participate in a research study about how a community health worker may influence follow-up care.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Chronic Conditions
  • Diabetes
  • Minority Health
  • Social or Workplace Dynamics
Visit Location
100% Remote (online, phone, text)
Open

IgA Nephropathy Microbiome Study

The purpose of this study is to compare diet (record of the foods you eat), gut microbiome (stool sample), and cells (blood sample) in adults with IgA Nephropathy (IgAN) and compare with adults with focal segmental glomerulosclerosis (FSGS) and adults with no history of medical problems. The information we learn by doing this study may help us understand how we might be able to target the microbiome to better understand the disease process and potentially help us develop new therapies in the future.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • Kidneys and Liver
  • Microbiome
Open

Diabetes Weight Loss Study

Do you have Type 2 Diabetes? Is your BMI in the obesity range and you want to lose weight? You may be eligible to participate in a research study to compare the effectiveness of Tirzepatide vs. a combination drug (Cagrilitide and Semaglutide)

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Diabetes
  • Obesity
Open

A study to test an oral medicine, belumosudil, in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease.

Are you diagnosed with chronic graft versus host disease (cGVHD)? If so, you might be able to take part in a study to evaluate the safety and efficacy of belumosudil in combination with corticosteroids.

Age & Gender
  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia, Lymphoma)
  • Transplant
Open

A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy

Are you premenopausal and have been diagnosed with ER-positive, HER2-negative breast cancer and had surgery for your breast cancer? If so, you may be able to take part in a research study evaluating the addition of chemotherapy given after breast surgery with ovarian suppression and endocrine therapy versus ovarian suppression and endocrine therapy alone.

Age & Gender
  • 18 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

Cancer Family History in Black Families

The survey and its findings will help us understand attitudes around cancer family history and genetic testing among Black people. This information will be used to develop an educational curriculum to strive towards health equity for Black people diagnosed with or at higher risk of cancer and get Black people the best cancer care.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Brain and Other Nervous System, Breast, and 18 more)
  • Healthy Volunteer or General Population
  • Minority Health
Visit Location
100% Remote (online, phone, text)
Open

THC Vaping Study

Do you use a THC vaping device? Help us learn more about what it does to your lungs. Compensation will be provided.

Age & Gender
  • 21 years ~ 40 years
  • Male, Female, Gender Inclusive
Study Interest
  • Lungs and Breathing
Open

Improving chronic kidney disease in type 1 diabetes

Do you have Type 1 Diabetes and Chronic Kidney Disease as a result of your diabetes? Do you want stop or slow the progression of your kidney disease? If so, you may be able to take part in the FINE-ONE study to learn more about a kidney drug called finerenone. Compensation is provided for participation.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
  • Kidneys and Liver
  • UNC Students (undergrad, grad, professional)
  • and 2 more
Open

Developing treatments for type 1 diabetes

We are studying different approaches to modify the activity of immune cells, such as T lymphocytes, that are involved in mediating type 1 diabetes. We need a small amount of blood to prepare T lymphocytes to test our therapies.

Age & Gender
  • 7 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Diabetes
  • Healthy Volunteer or General Population
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research